ArticleAmerican journal of cancer research2019

The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors.

Marc Yeste-Velasco et al.PubMed ↗Full text ↗

No numbers read from the abstract.